Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Proteomics and functional study reveal marginal zone B and B1 cell specific protein as a candidate marker of multiple myeloma

29 Apr 2020

Abstract excerpt

Multiple myeloma (MM) is a plasma cell‑associated cancer and accounts for 13% of all hematological malignancies, worldwide. MM still remains an incurable plasma cell malignancy with a poor prognosis due to a lack of suitable markers. Therefore, discovering novel markers and targets for diagnosis and therapeutics of MM is essential. The present study aims to identify markers associated with MM malignancy using...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Multiple Myeloma Research and Treatments
Share to Peptidase Inhibition and Analysis
Share to Protein Degradation and Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32377723
DOI: 10.3892/ijo.2020.5056

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Proteomics and functional study reveal marginal zone B and B1 cell specific protein as a candidate marker of multiple myelomaPMID 32377723Read ↗

Serum proteomic profiling reveals MTA2 and AGO2 as novel prognostic biomarkers associated with disease activity and adverse outcomes in multiple myelomaSemantic proximity Read ↗

Integrated Proteomic and Network Analysis Reveals Dysregulated Pathways and Candidate Proteins in Multiple Myeloma ProgressionSemantic proximity Read ↗

Identification of candidate therapeutics and signaling pathways for multiple myelomaSemantic proximity Read ↗

The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunitiesSemantic proximity Read ↗

Revised International Staging System (R-ISS) stage-dependent analysis uncovers oncogenes and potential immunotherapeutic targets in multiple myeloma (MM)Semantic proximity Read ↗

Identification of key candidate genes and pathways in multiple myeloma by integrated bioinformatics analysisSemantic proximity Read ↗

Distinct Pathway Activities are Associated with Prognosis and Response to Bortezomib- containing Treatment in MCL1-M Based Molecular Subtypes of Multiple MyelomaSemantic proximity Read ↗

Exploring the Molecular Mechanisms and Shared Genetic Characteristics of Monoclonal Gammopathy of Undetermined Significance and Multiple MyelomaSemantic proximity Read ↗

Genome-Wide Identification of Potential Biomarkers in Multiple Myeloma Using Meta-Analysis of mRNA and miRNA Expression DataSemantic proximity Read ↗

Identification of a novel lactylation-related gene signature predicts the prognosis of multiple myeloma and experiment verificationSemantic proximity Read ↗

Role of Non-Coding RNAs in Diagnosis, Prediction and Prognosis of Multiple MyelomaSemantic proximity Read ↗

Multiple Myeloma Bone Disease: Implication of MicroRNAs in Its Molecular BackgroundSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.